Prospective and observational study of antimicrobial drug utilization in medical intensive care unit in a tertiary care teaching hospital
DOI:
https://doi.org/10.7439/ijpr.v6i1.2886Keywords:
Cornelia de Lange, facial features, limb defects, oral featuresAbstract
Objectives: 1) The objective of this study was to assess the prescribing patterns of anti-microbial drugs. 2) Rationality of drug use in the medical ICU of a tertiary care hospital. Materials and Methods: After taking approval from the Institutional ethical committee, study was undertaken over a period of 6 months. A prospective observational study was conducted to assess the prescription pattern of antibiotic usage in the medical ICU. Standard Proforma was used to collect the information regarding antibiotics, its dose, duration, first line of antibiotics and second line of antibiotics and adverse drug reactions. Data was analysed using descriptive statistics with help of SPSS software. Results: Total 202 cases were admitted to the ICU during study period. Respiratory conditions (33.2%), febrile illness (15.3%), poisoning (15.3%) and CNS (12.9%) illnesses were commonly reported to ICU. Cephalosporins (81.7%) were commonly prescribed followed by Nitroimidazoles (30.2%) and Penicillin (16.3%). Ceftriaxone (43.1%) and cefixime (38.6%) were commonly used followed by Pipercillin + Tazobactum combination (9.4%). No adverse reactions were reported during the study period. Conclusion: In conclusion, a wide spectrum of clinical diagnoses and a variety of drugs were utilized from various drug classes. Results showed that Cephalosporins were extensively used in ICU. The number of drugs prescribed by generic names was low in the ICU and effort must be made to encourage prescribing by generic names. Rational usage of antimicrobial agents in ICU should be encouraged by following strict Hospital antimicrobial policy.Downloads
References
Goldman DA, Weinstein RA, Wenzel RP. Strategies to prevent and control the emergence of antimicrobial resistant micro-organisms in hospital. JAMA 1996; 275:234-49.
Townsend PL, Reynolds JR, Zaske DE. Applied Pharmacokinetics in the Intensive Care Unit. In, Irwin RS, Cerra FB, Rippe JM (ed). Irwin and Rippe
Espasito S, Leone S. Antimicrobial treatment intensive care unit (ICU) infections including the role of infectious diseases specialist. Int J Antimicrob Agents 2007; 29:494-500.
Lockhart SR, Abramson MA, Beekman SC, Gallanger G, Riedel SR, Diekman DJ et al. Antinicrobial resistance among gram negative bacilli as cause of infections in intensive care unit patients in United states between 1993 and 2004. J Clin Microbiol 2007; 45:3352-59.
Weber RJ, Kane SL, Oriolo VA, Saul M, Skledar SJ, Dasta JF. Impact of intensive drug cost. A descriptive analysis with recommendation for optimizing ICU pharmacotherapy. Cri Care Med 2003; 31:17-24.
Niederman MS. Appropriate use of antimicrobial agents: Challenges and strategies for improvement. Crit Care Med 2003; 31:608? 16.
Pulcine C, Pradier C, Samat?Long C, Hyvernat H, et al. Factors associated with adherence to infectious diseases advice in two intensive care units. J Antimicrob Chemother 2006; 57:546?50.
Brink A, Feldman C, Richards GA, Moolman G, Senekal M. Emergence of extensive drug resistance among gram negative bacilli in southafrica looms nearer. S Afr Med J 2008; 98:586-592.
Safadar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial resistance Staphylococcus aureus, Enterococcus, Gram negative bacilli, Clostridium difficle and Candida. Ann Intern Med 2002; 136:834-44.
Bassetti M, Di Biagio A, Rebesco B, Amalfitano ME, Topal J, Bassetti D. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol 2001; 57:529-34.
Keuleyan E, Gould M. Key issues in developing antibiotic policies: from an institutional level to Europe-wide. European Study Group on Antibiotic Policy (ESGAP), Subgroup III. Clin Microbiol Infect 2001; 7 (Suppl 6):16-21.
Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting. Crit Care 2001; 5:189
Srishyla MV, Naga Rani MA, Venkataraman BV: Drug utilization of antimicrobials in the in-patient setting of a tertiary hospital. Indian J Pharmacol 1994; 26:282-87.
Srishyla MV, Krishnamurthy M, Nagarani MA, et al. Prescription audit in an Indian hospital setting using the DDD (Defined Daily Dose) concept. Indian J Pharmacol 1994; 26:23?28.
R oberts AW, Visconti JA. The rational and irrational use of systemic antimicrobial drugs. Am J Hosp Pharm 1972; 29:828-34.
Pandiamunian J, Somasundaram G. A study on prescribing pattern of anti microbial agents in the medical intensive care unit of a tertiary care teaching hospital in Puducherry union territory, South India. Int J Pharm Pharm Sci 2014; 6(3):235-38.
Krivoy N, El-Ahal WA, Bar-Lavie Y, Haddad S. Antibiotic prescription and cost patterns in a general intensive care unit. Pharmacy Practice 2007; 5(2):67-73.
John LJ, Devi P, John J, Guido S. Drug utilization study of antimicrobial agents in medical intensive care unit of a tertiary care hospital. Asian J Pharm Clin Res 2011; 4(2):81-84.
Badar VA, Navale SB. Study of Prescribing Pattern of Antimicrobial Agents in Medicine Intensive Care Unit of a Teaching Hospital in Central India. JAPI April 2012; 60:20-23.
Williams A, Mathai AS, Phillips AS. Antibiotic prescription at admission into a tertiary level intensive care unit in Northern India. J Pharm Bioall Sci 2011; 3:531-36.
Amit GS. Drug Use Evaluation Study in a Tertiary Care Corporate Hospital with Special Reference to Use of Antibiotics in ICU Department. IJAPBC Jan- Mar, 2013; 2(1):179-89.
Adhikari A, Singh S, Bhowal T, Biswas S, Banerjee S, Ray M, et al. Study of prescribing pattern of antimicrobial agents in selected patients attending tertiary care hospital in India. Explor Anim Med Res. 2013; 3:29
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article